These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 21947421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A, Yue D, Liao D, Cheng L, Ma J, Wei Y, Tong A, Cheng P.
    Oncol Rep; 2016 Dec; 36(6):3283-3290. PubMed ID: 27748945
    [Abstract] [Full Text] [Related]

  • 3. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH, Lee SJ.
    J Cell Physiol; 2008 Oct 15; 217(1):23-33. PubMed ID: 18412143
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
    Kang N, Zhang JH, Qiu F, Tashiro S, Onodera S, Ikejima T.
    Cancer Lett; 2010 Aug 28; 294(2):147-58. PubMed ID: 20202741
    [Abstract] [Full Text] [Related]

  • 7. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H.
    Cancer Lett; 2011 Feb 01; 301(1):75-84. PubMed ID: 21078540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
    Calviño E, Estañ MC, Simón GP, Sancho P, Boyano-Adánez Mdel C, de Blas E, Bréard J, Aller P.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1619-29. PubMed ID: 21889928
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ, Lee JY, Kwak HJ, Park CM, Lee HC, Woo SH, Jin HO, Han CJ, An S, Lee SH, Chung HY, Park IC, Hong SI, Rhee CH.
    J Cell Biochem; 2005 Aug 01; 95(5):955-69. PubMed ID: 15962302
    [Abstract] [Full Text] [Related]

  • 11. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
    Li JJ, Tang Q, Li Y, Hu BR, Ming ZY, Fu Q, Qian JQ, Xiang JZ.
    Acta Pharmacol Sin; 2006 Aug 01; 27(8):1078-84. PubMed ID: 16867262
    [Abstract] [Full Text] [Related]

  • 12. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
    Cheng Y, Qiu F, Ye YC, Guo ZM, Tashiro S, Onodera S, Ikejima T.
    FEBS J; 2009 Mar 01; 276(5):1291-306. PubMed ID: 19187231
    [Abstract] [Full Text] [Related]

  • 13. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
    Shen P, Jiang T, Lu H, Han H, Luo R.
    Cell Biol Int; 2011 Aug 01; 35(8):803-10. PubMed ID: 21418039
    [Abstract] [Full Text] [Related]

  • 14. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar 01; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 15. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Diaz Z, Laurenzana A, Mann KK, Bismar TA, Schipper HM, Miller WH.
    Leukemia; 2007 Oct 01; 21(10):2117-27. PubMed ID: 17690699
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X, Liu F, Li M.
    Anticancer Drugs; 2016 Apr 01; 27(4):286-99. PubMed ID: 26704389
    [Abstract] [Full Text] [Related]

  • 17. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
    Woo SH, Park IC, Park MJ, Lee HC, Lee SJ, Chun YJ, Lee SH, Hong SI, Rhee CH.
    Int J Oncol; 2002 Jul 01; 21(1):57-63. PubMed ID: 12063550
    [Abstract] [Full Text] [Related]

  • 18. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.
    Ying M, Tu C, Ying H, Hu Y, He Q, Yang B.
    J Pharmacol Exp Ther; 2008 Jun 01; 325(3):758-65. PubMed ID: 18323457
    [Abstract] [Full Text] [Related]

  • 19. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y, Simón GP, Calviño E, de Blas E, Aller P.
    J Pharmacol Exp Ther; 2010 Oct 01; 335(1):114-23. PubMed ID: 20605902
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y, Zhang J.
    Toxicol Lett; 2014 Nov 18; 231(1):55-61. PubMed ID: 25196641
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.